David Fuller
Hoofd Techniek/Wetenschap/O&O bij DIMERIX LIMITED
Vermogen: 1 869 $ op 31-05-2024
Actieve functies van David Fuller
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ADALTA LIMITED | Directeur/Bestuurslid | 22-07-2020 | - |
| DIMERIX LIMITED | Hoofd Techniek/Wetenschap/O&O | 23-10-2023 | - |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Voorzitter | - | - |
Loopbaan van David Fuller
Eerdere bekende functies van David Fuller
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RACE ONCOLOGY LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-07-2021 | 11-11-2022 |
Statistieken
Internationaal
| Australië | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectoraal
| Health Technology | 5 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ADALTA LIMITED | Health Technology |
| RACE ONCOLOGY LIMITED | Health Technology |
| DIMERIX LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
- Beurs
- Insiders
- David Fuller
- Ervaring
